XML Financial’s Heron Therapeutics HRTX Stock Holding History

XML Financial’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,000	Closed	-$13K	–	440
2025 Q4	$13K	Hold	10,000	–	–	﹤0.01%	441
2025 Q3	$12.6K	Hold	10,000	–	–	﹤0.01%	391
2025 Q2	$20.7K	Hold	10,000	–	–	﹤0.01%	390
2025 Q1	$22K	Hold	10,000	–	–	﹤0.01%	369
2024 Q4	$15.3K	Hold	10,000	–	–	﹤0.01%	356
2024 Q3	$19.9K	Hold	10,000	–	–	﹤0.01%	346
2024 Q2	$35K	Hold	10,000	–	–	﹤0.01%	335
2024 Q1	$27.7K	Hold	10,000	–	–	﹤0.01%	338
2023 Q4	$17K	Buy	+10,000	New	+$11K	﹤0.01%	332

Other funds holding HRTX

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return